# OnCo record paper-gravis-getug-afu-15-docetaxel-lancet-oncol-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gravis-getug-afu-15-docetaxel-lancet-oncol-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gravis-getug-afu-15-docetaxel-lancet-oncol-2013" ;
  schema:name "GETUG-AFU 15: androgen deprivation alone or with docetaxel in non-castrate metastatic prostate cancer"@en ;
  schema:alternateName "GETUG-AFU 15"@en, "GETUG 15"@en, "Gravis 2013 docetaxel hormone-sensitive"@en ;
  schema:description "The first trial to give chemotherapy at the same time as hormone therapy in newly diagnosed metastatic prostate cancer. It found no survival benefit and concluded against the approach, two years before two larger trials found the opposite."@en ;
  schema:url <https://onco.cc/key-papers/paper-gravis-getug-afu-15-docetaxel-lancet-oncol-2013/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(12)70560-0>, <https://pubmed.ncbi.nlm.nih.gov/23306100/>, <https://clinicaltrials.gov/study/NCT00104715> ;
  onco:tag "prostate-evidence" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(12)70560-0> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Gravis G, Fizazi K, Joly F, et al." ;
  onco:related <https://onco.cc/key-papers/paper-chaarted-nejm-2015/>, <https://onco.cc/key-papers/paper-stampede-lancet-2016/>, <https://onco.cc/key-papers/paper-vale-stopcap-docetaxel-bisphosphonates-lancet-oncol-2016/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mhspc/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/hormonal/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/> ;
  onco:terms <https://onco.cc/terms/adt/>, <https://onco.cc/terms/hazard-ratio/> ;
  onco:people <https://onco.cc/people/karim-fizazi/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-negative-results/>, <https://onco.cc/bottlenecks/b-trial-enrolment/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .